「place」の検索結果
39件：11～15件目を表示
-
学会发表 | 研究与开发 | 千寿制药株式会社
Kong Motugivatrep, a TRPV1 antagonist in Dry Eye Patients – Results of a Randomized, Double-Masked, Placebo-Controlled Phase 3 Pivotal Study – Yuichi Hori, MD, PhD; Tomoyuki Wada, PhD; Minoru Kanamoto...
https://www.senju.co.jp/chinese/rd/society/ -
論文投稿実績 | 研究開発活動 | 千寿製薬株式会社
開発本部 メディカルアフェアーズ部 ＊2 ケイシン五反田アイクリニック 医学と薬学, 83(1) 1-11, 2026 Results of a Randomized, Double-Masked, Placebo-Controlled Phase 1/2 Study of a TRPV1 Antagonist SJP-0132 in Participants With Dry Eye Disea...
https://www.senju.co.jp/rd/thesis/ -
学会発表実績 | 研究開発活動 | 千寿製薬株式会社
Kong Motugivatrep, a TRPV1 antagonist in Dry Eye Patients – Results of a Randomized, Double-Masked, Placebo-Controlled Phase 3 Pivotal Study – Yuichi Hori, MD, PhD; Tomoyuki Wada, PhD; Minoru Kanamoto...
https://www.senju.co.jp/rd/society/ -
Meetings of the Minds | Research & Development | SENJU Pharmaceutica
Kong Motugivatrep, a TRPV1 antagonist in Dry Eye Patients – Results of a Randomized, Double-Masked, Placebo-Controlled Phase 3 Pivotal Study – Yuichi Hori, MD, PhD; Tomoyuki Wada, PhD; Minoru Kanamoto...
http://www.senju.co.jp/english/rd/society/ -
Mytear HARD LENS WETTING SOLUTION | OTC Products, etc. | Products | SENJU Pharmaceutical
ections. PRECAUTIONS FOR STORAGE AND HANDLING Keep the bottle tightly closed and store it in a cool place away from direct sunlight. Keep out of the reach of children. To prevent improper use or loss ...
https://www.senju.co.jp/english/products/wettingsolution.html